Urology Times
@urologytimes
The Leading News Source for Urologists - UrologyTimes.com
Expert clinical analysis. Practice advice. Policy perspectives.
ID: 532214911
http://www.urologytimes.com 21-03-2012 13:12:09
30,30K Tweet
23,23K Takipçi
2,2K Takip Edilen
The first patient has been dosed in the phase 2a LEGION-100 trial, evaluating SYNC-T therapy SV-102 in patients with mCRPC. #pcsm Jason Hafron urologytimes.com/view/phase-2-t…